StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3055% below fair value
$41.98−1.01 (-2.35%)

Close on Nov 20, 2026Market cap $60.84BP/E 17.0Yield –

Boston Scientific Restructuring Accrual Reserve Balance by Quarter

Restructuring Accrual Reserve Balance ($M) ($M)

Boston Scientific Restructuring Accrual Reserve Balance: $48M in Q3 2026.

Latest, Q3 2026
48
Period ended Sep 30, 2026
Change on a year earlier
–
History
5 quarters
Since Q4 2022
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗

Reported in Form 10-K/10-Q Restructuring Footnote.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring Accrual Reserve Balance ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202648–Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗
Q4 2025Dec 31, 202559+126.9%Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗
Q4 2024Dec 31, 202426-36.6%Form EX21 — FY2025 (filed 2026-02-17) ↗
Q4 2023Dec 31, 202341+310.0%Form EX21 — FY2024 (filed 2025-02-18) ↗
Q4 2022Dec 31, 202210–Form 10-K — FY2023 (filed 2024-02-20) ↗

Breakdown

What makes up restructuring Accrual Reserve Balance

Cite this data

StockData. (2026). Boston Scientific Restructuring Accrual Reserve Balance ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/fn-restruct-res

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?